Skip to main content

Table 1 SHCS Patient Characteristics

From: Immunophenotypic characterization of TCR γδ T cells and MAIT cells in HIV-infected individuals developing Hodgkin’s lymphoma

 

HIV+ w/o HL group (n = 10)

HIV+ HL+ group (n = 10)

w/o HL vs. HL+ (p-value)

Gender

 Male

10

10

NA

Ethnicity

 Caucasian

10

10

NA

Age at HIV diagnosis, median (IQR)

34.5 (28.75, 38)

31 (26.75, 39)

0.1211

Baseline plasma viral load (copies per ml), median (IQR)

25,865 (11,730, 51,475)

24,092 (14,550, 739,500)

0.1602

Baseline CD4+ T cell count per ul, median (IQR)

523 (368, 602)

448 (310, 526)

0.3750

Years between HIV diagnosis and initiation of cART, median (IQR)

3 (1.5, 3.25)

2 (0, 2.5)

0.4688

Duration cART in days, median (IQR)

976 (717, 1457)

1382 (568, 2328)

0.3750

cART included EFV (%)

30%

60%

0.3698i

Age at HL diagnosis,

median (IQR)

NA

39 (34, 44.25)

 
  1. Abbreviations: cART combined antiretroviral therapy, HL Hodgkin’s lymphoma, EFV Efavirenz
  2. Statistical analysis: Wilcoxon signed-rank test and iexact Fisher’s test